Yuan Y - Search Results

1

Identification of integrative molecular and clinical profiles of Fibrinogen-like protein 2 in gliomas using 1323 samples.

Song Z, Wang Y, Du Y, Zhang Z, Yuan Y. Song Z, et al. Among authors: yuan y. Int Immunopharmacol. 2020 Nov;88:106894. doi: 10.1016/j.intimp.2020.106894. Epub 2020 Aug 25. Int Immunopharmacol. 2020. PMID: 32858440

2

Expression Profiles of microRNAs in Drug-Resistant Non-Small Cell Lung Cancer Cell Lines Using microRNA Sequencing.

Hu S, Yuan Y, Song Z, Yan D, Kong X. Hu S, et al. Among authors: yuan y. Cell Physiol Biochem. 2018;51(6):2509-2522. doi: 10.1159/000495921. Epub 2018 Dec 17. Cell Physiol Biochem. 2018. PMID: 30557872 Free article.

3

CDK11^p110 plays a critical role in the tumorigenicity of esophageal squamous cell carcinoma cells and is a potential drug target.

Du Y, Yan D, Yuan Y, Xu J, Wang S, Yang Z, Cheng W, Tian X, Kan Q. Du Y, et al. Among authors: yuan y. Cell Cycle. 2019 Feb;18(4):452-466. doi: 10.1080/15384101.2019.1577665. Epub 2019 Feb 12. Cell Cycle. 2019. PMID: 30722725 Free PMC article.

4

In vitro metabolic profiles of motolimod by using liquid chromatography tandem mass spectrometry: Metabolic stability, metabolite characterization and species comparison.

Li Z, Zhao S, Yuan Y, Zhang L, Song Z, Tian X, Zhang X. Li Z, et al. Among authors: yuan y. J Pharm Biomed Anal. 2019 Apr 15;167:90-99. doi: 10.1016/j.jpba.2019.02.009. Epub 2019 Feb 7. J Pharm Biomed Anal. 2019. PMID: 30763883

5

Characterization of transcriptome profile and clinical features of a novel immunotherapy target CD204 in diffuse glioma.

Yuan Y, Zhao Q, Zhao S, Zhang P, Zhao H, Li Z, Du Y, Tian X, Lu J. Yuan Y, et al. Cancer Med. 2019 Jul;8(8):3811-3821. doi: 10.1002/cam4.2312. Epub 2019 May 29. Cancer Med. 2019. PMID: 31140757 Free PMC article.

6

Polyphyllin VI induces apoptosis and autophagy in human osteosarcoma cells by modulation of ROS/JNK activation.

Yuan YL, Jiang N, Li ZY, Song ZZ, Yang ZH, Xue WH, Zhang XJ, Du Y. Yuan YL, et al. Drug Des Devel Ther. 2019 Aug 28;13:3091-3103. doi: 10.2147/DDDT.S194961. eCollection 2019. Drug Des Devel Ther. 2019. PMID: 31695327 Free PMC article.

7

Integrated quality evaluation strategy for multi-species resourced herb medicine of Qinjiao by metabolomics analysis and genetic comparation.

Li Z, Du Y, Yuan Y, Zhang X, Wang Z, Tian X. Li Z, et al. Among authors: yuan y. Chin Med. 2020 Feb 11;15:16. doi: 10.1186/s13020-020-0292-3. eCollection 2020. Chin Med. 2020. PMID: 32071612 Free PMC article.

8

Analysis of lncRNA, miRNA and mRNA-associated ceRNA networks and identification of potential drug targets for drug-resistant non-small cell lung cancer.

Kong X, Hu S, Yuan Y, Du Y, Zhu Z, Song Z, Lu S, Zhao C, Yan D. Kong X, et al. Among authors: yuan y. J Cancer. 2020 Mar 5;11(11):3357-3368. doi: 10.7150/jca.40729. eCollection 2020. J Cancer. 2020. PMID: 32231742 Free PMC article.

9

A GLP-1/glucagon (GCG)/CCK₂ receptors tri-agonist provides new therapy for obesity and diabetes.

Zhao S, Yan Z, Du Y, Li Z, Tang C, Jing L, Sun L, Yang Q, Tang X, Yuan Y, Han J, Jiang N. Zhao S, et al. Among authors: yuan y. Br J Pharmacol. 2022 Sep;179(17):4360-4377. doi: 10.1111/bph.15860. Epub 2022 May 20. Br J Pharmacol. 2022. PMID: 35484823 Free article.

10

Discovery of METTL3 Small Molecule Inhibitors by Virtual Screening of Natural Products.

Du Y, Yuan Y, Xu L, Zhao F, Wang W, Xu Y, Tian X. Du Y, et al. Among authors: yuan y. Front Pharmacol. 2022 Apr 27;13:878135. doi: 10.3389/fphar.2022.878135. eCollection 2022. Front Pharmacol. 2022. PMID: 35571106 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

21,604 results

Search Page

Filters